Circ Pharma recognises the mutual benefits to be achieved from working with partners. Circ Pharma's management team have significant commercial experience in efficiently executing and managing partnership relationships in a flexible and mutually beneficial manner coupled with strong program management skills to drive successful projects.
Circ Pharma is actively looking to co-develop and out-license current products in its pipeline in the areas of cardiovascular disease and CNS and Pain (see section on pipeline for available opportunities).
Our intellectual property and technology for centrally acting drugs (see CNS & Pain pipeline section for more information) is amenable to the development of a broad range of drug candidates that fall within its parameters. If you would like to further explore the applicability of this technology to your compounds please contact us.
For business development enquiries contact:
Margot Foynes - Chief Technical Officer
Direct Telephone: +353 1 634 4186
Direct Fax: +353 1 634 4188
Email: margot.foynes@circpharma.com
Circ Pharma is actively looking to co-develop and out-license current products in its pipeline in the areas of cardiovascular disease and CNS and Pain (see section on pipeline for available opportunities).
Our intellectual property and technology for centrally acting drugs (see CNS & Pain pipeline section for more information) is amenable to the development of a broad range of drug candidates that fall within its parameters. If you would like to further explore the applicability of this technology to your compounds please contact us.
For business development enquiries contact:
Margot Foynes - Chief Technical Officer
Direct Telephone: +353 1 634 4186
Direct Fax: +353 1 634 4188
Email: margot.foynes@circpharma.com